Oxcarbazepine Extended-Release Tablets and Sodium oxybate
Determining the interaction of Oxcarbazepine Extended-Release Tablets and Sodium oxybate and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Using sodium oxybate together with OXcarbazepine may increase side effects such as drowsiness, dizziness, lightheadedness, confusion, depression, low blood pressure, slow or shallow breathing, and impairment in thinking, judgment, and motor coordination. Occasionally, severe reactions may result in coma and even death. Talk to your doctor if you have any questions or concerns. Your doctor may be able to prescribe alternatives that do not interact, or you may need a dose adjustment or more frequent monitoring by your doctor to safely use both medications. You should avoid the use of alcohol while being treated with these medications. Also avoid driving, operating machinery, or engaging in potentially hazardous activities requiring mental alertness and motor coordination for at least six hours after taking sodium oxybate and until you know how the medications affect you, and use caution when getting up from a sitting or lying position. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:GENERALLY AVOID: The central nervous system and respiratory depressant effects of sodium oxybate, which is the sodium salt of gamma hydroxybutyrate (GHB), may be potentiated by concomitant use of other agents with CNS depressant effects. An increased risk of serious adverse reactions such as respiratory depression, hypotension, profound sedation, syncope, coma, and even death should be considered.
MANAGEMENT: Concomitant use of sodium oxybate with other CNS depressants should be avoided whenever possible. Otherwise, close monitoring and/or dosage reductions should be considered. If short-term use of a CNS depressant is required (e.g., post- or perioperative opioid), a temporary interruption of sodium oxybate therapy may be appropriate. All patients treated with sodium oxybate should be advised not to drive, operate machinery, or engage in potentially hazardous activities requiring mental alertness and motor coordination for at least 6 hours after taking the second nightly dose of sodium oxybate and until they know how the medication affects them.
- "Product Information. Xyrem (sodium oxybate)." Orphan Medical, Minnetonka, MN.
Generic Name: oxcarbazepine
Brand name: Oxtellar XR, Trileptal
Synonyms: Oxcarbazepine, OXcarbazepine
Generic Name: sodium oxybate
Brand name: Xyrem
Synonyms: Sodium Oxybate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Oxcarbazepine Extended-Release Tablets-Sodium phenylacetate and benzoate Intravenous
- Oxcarbazepine Extended-Release Tablets-Sodium Phenylacetate and Sodium Benzoate
- Oxcarbazepine Extended-Release Tablets-Sodium Phenylacetate and Sodium Benzoate Injection
- Oxcarbazepine Extended-Release Tablets-Sodium phenylbutyrate
- Oxcarbazepine Extended-Release Tablets-Sodium Phenylbutyrate Powder
- Oxcarbazepine Extended-Release Tablets-Sodium Phenylbutyrate Tablets
- Sodium oxybate-Oxcarbazepine Oral Suspension
- Sodium oxybate-Oxcarbazepine Suspension
- Sodium oxybate-Oxcarbazepine Tablets
- Sodium oxybate-Oxecta
- Sodium oxybate-Oxilan
- Sodium oxybate-Oxipor VHC